Publication | Closed Access

Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β

InflammationMolecular PharmacologyPain TherapyHealth SciencesAcute PainPain MedicineMedicineImmunologyToll-like ReceptorNeuropathic PainMolecular PainNeuropharmacologyPain ManagementPain MechanismIntrathecal Morphine-3-glucuronidePharmacologyAnalgesicsPain Research